GlassScriptPhysician profile
Denise Umpierrez-Morley
NPI 1679992168
$7,150.80
in general payments reported to CMS, 2019-2025
32 companies · $327 in 2025
The $327 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $167 · 2020: $239 · 2021: $261 · 2022: $2,342 · 2023: $3,061 · 2024: $753 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,973 · Travel and Lodging: $1,131 · Education: $1,000 · Gift: $37.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,972.86 |
| Travel and Lodging | $1,130.97 |
| Education | $1,000.00 |
| Gift | $37.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,102.40 | 2022-2024 | Da Vinci Surgical System, Davinci Xi |
| Abbvie INC. | $361.58 | 2019-2023 | Lo Loestrin Fe |
| Astellas Pharma US INC | $181.94 | 2020-2025 | Veozah, Myrbetriq |
| Coopersurgical, INC. | $170.28 | 2019-2023 | Summit Doppler |
| Biogen, INC. | $145.57 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $120.10 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $112.40 | 2019-2024 | |
| Hologic Sales and Service, LLC | $107.25 | 2022-2025 | Acessa Provu System, Thinprep 2000 Processor, Aptima |
| Aspira Women'S Health INC | $93.45 | 2022 | |
| Therapeuticsmd, INC. | $89.67 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $78.44 | 2021-2025 | |
| Organon LLC | $53.97 | 2024 | |
| Merck Sharp & Dohme LLC | $49.25 | 2021-2025 | Gardasil 9 |
| Evofem Biosciences, INC. | $47.43 | 2024-2025 | Solosec, Phexx, Phexxi |
| Millicent US INC | $44.87 | 2024-2025 | Intrarosa, Femlyv |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $41.36 | 2022-2025 | Pico 7, Pico 14 |
| Sumitomo Pharma America, INC. | $40.36 | 2023-2025 | Myfembree |
| Agile Therapeutics, INC. | $40.03 | 2021-2022 | |
| Daiichi Sankyo INC. | $32.70 | 2019-2020 | |
| Shield Therapeutics INC | $22.83 | 2024 | |
| Allergan, INC. | $22.82 | 2019-2020 | |
| Convatec INC. | $22.61 | 2023 | |
| Roche Diagnostics Corporation | $22.11 | 2019 | |
| Ethicon US, LLC | $21.14 | 2020 | |
| Bsn Medical INC | $19.81 | 2025 | |
| Baxter Healthcare | $18.16 | 2024 | Perclot |
| Abbott Laboratories | $17.95 | 2023 | Freestyle Libre 3 |
| Meditrina | $14.87 | 2024 | |
| Vertical Pharmaceuticals, LLC | $14.48 | 2019 | |
| Avanos Medical | $14.38 | 2020 | |
| Amag Pharmaceuticals, INC. | $13.96 | 2020 | |
| Scynexis, INC. | $12.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Umpierrez-Morley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.